TW200745105A - Non-steroidal glucocorticoid receptor modulators - Google Patents

Non-steroidal glucocorticoid receptor modulators

Info

Publication number
TW200745105A
TW200745105A TW095129231A TW95129231A TW200745105A TW 200745105 A TW200745105 A TW 200745105A TW 095129231 A TW095129231 A TW 095129231A TW 95129231 A TW95129231 A TW 95129231A TW 200745105 A TW200745105 A TW 200745105A
Authority
TW
Taiwan
Prior art keywords
alkyl
halogen
optionally substituted
hetero
aryl
Prior art date
Application number
TW095129231A
Other languages
English (en)
Other versions
TWI375676B (en
Inventor
Ralf Plate
Christiaan Gerardus Johannes Maria Jans
Original Assignee
Organon Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon Nv filed Critical Organon Nv
Publication of TW200745105A publication Critical patent/TW200745105A/zh
Application granted granted Critical
Publication of TWI375676B publication Critical patent/TWI375676B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Otolaryngology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
TW095129231A 2005-08-29 2006-08-09 Non-steroidal glucocorticoid receptor modulators TWI375676B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05107896 2005-08-29

Publications (2)

Publication Number Publication Date
TW200745105A true TW200745105A (en) 2007-12-16
TWI375676B TWI375676B (en) 2012-11-01

Family

ID=35466054

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095129231A TWI375676B (en) 2005-08-29 2006-08-09 Non-steroidal glucocorticoid receptor modulators

Country Status (30)

Country Link
US (1) US8575152B2 (zh)
EP (1) EP1924580B1 (zh)
JP (1) JP5191383B2 (zh)
KR (1) KR20080040024A (zh)
CN (1) CN101304999B (zh)
AR (1) AR058027A1 (zh)
AT (1) ATE421516T1 (zh)
AU (1) AU2006286524B2 (zh)
BR (1) BRPI0615412A2 (zh)
CA (1) CA2621229A1 (zh)
CY (1) CY1109041T1 (zh)
DE (1) DE602006005006D1 (zh)
DK (1) DK1924580T3 (zh)
EC (1) ECSP088289A (zh)
ES (1) ES2320273T3 (zh)
HR (1) HRP20090116T3 (zh)
IL (1) IL189463A (zh)
MY (1) MY145591A (zh)
NO (1) NO20080940L (zh)
NZ (1) NZ566005A (zh)
PE (1) PE20070331A1 (zh)
PL (1) PL1924580T3 (zh)
PT (1) PT1924580E (zh)
RS (1) RS50763B (zh)
RU (1) RU2420528C2 (zh)
SI (1) SI1924580T1 (zh)
TW (1) TWI375676B (zh)
UA (1) UA92024C2 (zh)
WO (1) WO2007025938A1 (zh)
ZA (1) ZA200801599B (zh)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103130717B (zh) * 2011-11-29 2015-04-01 上海博康精细化工有限公司 二苯并氮卓酮的制备方法
WO2025255469A1 (en) * 2024-06-06 2025-12-11 Psammiad Therapeutics, Inc. Compounds and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3657250A (en) * 1970-02-10 1972-04-18 Ayerst Mckenna & Harrison Benzocycloheptaisoquinoline derivatives
IL36085A (en) * 1970-02-10 1974-09-10 Ayerst Mckenna & Harrison Octahydrobenzo(6,7)cyclohepta(1,2,3-d,a)pyrido(or pyrrolo)-(2,1-a)isoquinolines and decahydrobenzo-(6,7)cyclohepta-(1,2,3-d,e)azepino(2,1-a)isoquinolines and their preparation
NL7305811A (zh) * 1973-04-26 1974-10-29
US4016161A (en) * 1974-04-24 1977-04-05 Akzona Incorporated Amino-substituted 1,2,3,4,10,146-hexahydro-pyridino[1,2-a]dibenzo[c,f]azepines
EP1043325B1 (en) * 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
IL146057A (en) * 2000-10-27 2007-09-20 Pfizer Prod Inc A process for the preparation of modulators of a non-steroidal glucocorticoid receptor
TWI297685B (en) * 2002-04-04 2008-06-11 Organon Nv Non-steroidal progesterone receptor modulators
EP1534273A4 (en) 2002-07-18 2007-08-22 Bristol Myers Squibb Co MODULATORS OF THE GLUCOCORTICOID RECEPTOR AND METHOD

Also Published As

Publication number Publication date
UA92024C2 (ru) 2010-09-27
RU2008112206A (ru) 2009-10-10
NZ566005A (en) 2010-01-29
PL1924580T3 (pl) 2009-07-31
CN101304999A (zh) 2008-11-12
RU2420528C2 (ru) 2011-06-10
AU2006286524B2 (en) 2011-06-16
EP1924580B1 (en) 2009-01-21
DK1924580T3 (da) 2009-05-11
BRPI0615412A2 (pt) 2012-12-04
CA2621229A1 (en) 2007-03-08
ECSP088289A (es) 2008-04-28
KR20080040024A (ko) 2008-05-07
US8575152B2 (en) 2013-11-05
CN101304999B (zh) 2011-11-16
ES2320273T3 (es) 2009-05-20
TWI375676B (en) 2012-11-01
AU2006286524A1 (en) 2007-03-08
AR058027A1 (es) 2008-01-23
PE20070331A1 (es) 2007-04-16
NO20080940L (no) 2008-05-05
WO2007025938A1 (en) 2007-03-08
RS50763B (sr) 2010-08-31
DE602006005006D1 (de) 2009-03-12
ATE421516T1 (de) 2009-02-15
JP2009506093A (ja) 2009-02-12
IL189463A0 (en) 2008-06-05
US20080188459A1 (en) 2008-08-07
HRP20090116T3 (en) 2009-04-30
SI1924580T1 (sl) 2009-06-30
PT1924580E (pt) 2009-04-01
MY145591A (en) 2012-02-29
IL189463A (en) 2011-07-31
CY1109041T1 (el) 2014-07-02
EP1924580A1 (en) 2008-05-28
JP5191383B2 (ja) 2013-05-08
ZA200801599B (en) 2009-01-28

Similar Documents

Publication Publication Date Title
ES2893099T3 (es) Acidos hidroxámicos bicíclicos útiles como inhibidores de la actividad de histona desacetilasa de mamíferos
ES2974334T3 (es) Inhibidores heterocíclicos de ATR cinasa
JP7290627B2 (ja) Ａｔｒキナーゼの複素環式阻害剤
PE20030129A1 (es) Imidazotriazinas
CO5251463A1 (es) Compuestos heterociclicos y composicion farmaceutica que coniene dichos compuestos
AR065276A1 (es) Herbicidas de n-oxidos de piridina sustituidos
JP2013542204A (ja) 細菌トポイソメラーゼｉｉ阻害性２−エチルカルバモイルアミノ−１，３−ベンゾチアゾール−５−イル類
CY1114908T1 (el) Παραγωγα κινολινης ως αντιβακτηριακοι παραγοντες
RU2009140149A (ru) Пиримидингидразидные соединения как ингибиторы pgds
MY141245A (en) Macrocylic inhibitors of hepatitis c virus
AR051469A1 (es) Derivados de indol tetraciclicos como agentes antiviricos
AR053436A1 (es) Iderivados de 3-(indazol-5-il)-(1,2,4)triazina inhibidores de quinasas
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
HRP20141169T1 (hr) Makrocikliäśki inhibitori serin proteaze hepatitisa c
EP2424867A1 (en) 5,6,7,8-tetrahydroimidazo[1,2-a]pyrazine derivatives as p2x7 modulators
DK1442019T3 (da) Amidderivater som glycogensynthasekinase 3- beta-inhibitorer
BR0313923A (pt) Derivados de 3-(sulfonamidoetil)-indol para uso como miméticos de glicocorticóide no tratamento de doenças inflamatórias, alérgicas e proliferativas
AR064608A1 (es) Derivados de pirazolo-quinazolina sustituidos, composiciones farmaceuticas que los contienen. proceso para su preparacion y uso de los mismos como agentes anticancer.
NO20070484L (no) Sammenspleisede pyrimidinderivater og sammensetninger derav som CXCR3 reseptormodulatorer, anvendbare ved forebygging og behandling av inflammatoriske og immunregulatoriske lidelser og sykdommer.
DE60315677D1 (de) Pyrazolopyridin derivate als tgf beta hemmstoffe zur behandlung von krebs
PE20090291A1 (es) Amidas disustituidas para mejorar las respuestas sinapticas glutamatergicas
BRPI0713684A2 (pt) compostos, composição farmaceuticamente aceitável e métodos de inibição da replicação de vìrus da hepatite c, de tratamento de célula e de tratamento ou prevenção da infecção do vìrus da hepatite c em maìfero carecido do mesmo
JP2021518344A (ja) Ａｔｒキナーゼの複素環式阻害剤
WO2009010789A3 (en) Pyrimidine derivatives 934
DE602004026095D1 (de) Chinoloncarbonsäureverbindungen mit 5-ht4-rezeptoragonistischer wirkung

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees